The TSP carcinoembryonic antigen promoter (CEA), COX-2, MK or the tissue specific insulin promoter have been used to target TK gene expression in pancreatic cancer [127-129]. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.